Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in Vietnam
Vietnam: Diphtheria tetanus toxoid and pertussis third-dose (DTP3) was 97.0% in 2025. ▼ Falling
Latest (2025)
97.0%
Change on year
unchanged
World rank
33rd
of 194 countries
All-time high
99.0%
in 2003
All-time low
59.0%
in 2013
Years of data
26
2000–2025
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in Vietnam, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Vietnam recorded 97.0% for diphtheria tetanus toxoid and pertussis third-dose (dtp3) in 2025.
The figure is unchanged over ten years.
Over the whole period, diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Vietnam peaked at 99.0% in 2003 and was at its lowest, 59.0%, in 2013.
Vietnam ranks 33rd of 194 countries on this measure, in the top quarter.
The long-run direction has been consistently falling across the 26 years of available data.
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in Vietnam, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 96.0% | — |
| 2001 | 96.0% | +0.0% |
| 2002 | 75.0% | -21.9% |
| 2003 | 99.0% | +32.0% |
| 2004 | 96.0% | -3.0% |
| 2005 | 95.0% | -1.0% |
| 2006 | 94.0% | -1.1% |
| 2007 | 92.0% | -2.1% |
| 2008 | 93.0% | +1.1% |
| 2009 | 96.0% | +3.2% |
| 2010 | 93.0% | -3.1% |
| 2011 | 95.0% | +2.2% |
| 2012 | 97.0% | +2.1% |
| 2013 | 59.0% | -39.2% |
| 2014 | 95.0% | +61.0% |
| 2015 | 97.0% | +2.1% |
| 2016 | 96.0% | -1.0% |
| 2017 | 94.0% | -2.1% |
| 2018 | 75.0% | -20.2% |
| 2019 | 89.0% | +18.7% |
| 2020 | 94.0% | +5.6% |
| 2021 | 83.0% | -11.7% |
| 2022 | 91.0% | +9.6% |
| 2023 | 65.0% | -28.6% |
| 2024 | 97.0% | +49.2% |
| 2025 | 97.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 93.2% | 75.0% | 99.0% | 10 |
| 2010s | 89.0% | 59.0% | 97.0% | 10 |
| 2020s | 87.8% | 65.0% | 97.0% | 6 |
Countries ranked near Vietnam
More health data for Vietnam
- Un projection of annual infant deaths, annual growth rate -1.66 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0536 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,306 deaths per 1,000 people (2090)
- Number of infants who die before age 1 3,132 deaths (2100)
- Population ages 0-14, female, annual growth rate -1.16 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.1104 units per person (2025)
- Population ages 0-14, male, annual growth rate -0.8301 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1182 units per person (2025)
Frequently asked questions
- What is diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Vietnam?
- Diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Vietnam was 97.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest diphtheria tetanus toxoid and pertussis third-dose (dtp3) recorded in Vietnam?
- The highest recorded value was 99.0% in 2003.
- What is the lowest diphtheria tetanus toxoid and pertussis third-dose (dtp3) recorded in Vietnam?
- The lowest recorded value was 59.0% in 2013.
- How does Vietnam rank for diphtheria tetanus toxoid and pertussis third-dose (dtp3)?
- Vietnam ranks 33rd out of 194 countries with data for 2025.
- Is diphtheria tetanus toxoid and pertussis third-dose (dtp3) rising or falling in Vietnam?
- Over the last ten years it is unchanged. The long-run trend across the full record is falling.
- Where does this Vietnam data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Diphtheria tetanus toxoid and pertussis third-dose (DTP3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).